Blood Analyzers in New Jersey

Ethos Biosciences is a holding company established in 2018 that designs, develops, and manufactures high-quality diagnostic test kits and laboratory reagents. The company operates through several branded divisions: Exocell (founded with 30+ years of experience), Astral Diagnostics (20+ years), American Bionostica (established 2000), and subsidiaries including Polysciences (founded 1961) and Bangs Laboratories (founded 1988). Exocell specializes in ELISA kits, antibodies, hemoglobin standards, and diluents primarily for research and clinical applications in kidney disease, diabetes, and cardiovascular disorders. Astral Diagnostics manufactures laboratory and clinical stains and reagents across hematology, histology, cytology, microbiology, and veterinary pathology. American Bionostica produces lateral flow devices and assays for OEM clients across food safety, agricultural, environmental, veterinary, biodefense, and clinical sectors. Polysciences offers specialty chemicals, custom synthesis, and contract manufacturing for life sciences and bioprocessing. Bangs Laboratories manufactures microsphere-based reagents and analytical calibrators for in vitro diagnostics and research. Products are used in experimental research, clinical diagnostics, and veterinary applications. The company maintains manufacturing and distribution facilities in Logan Township, New Jersey and Newtown Square, Pennsylvania.

Alfa Wassermann Diagnostic Technologies (AWDT) manufactures and supplies clinical chemistry analyzers for physician offices, hospitals, veterinary clinics, and the biopharmaceutical industry. The company is part of the larger Alfa Wassermann group, which operates through two primary divisions: AWDT (diagnostic technologies) and AWST (Alfa Wassermann Separation Technologies, focused on ultracentrifuges for vaccine and gene therapy manufacturing). AWDT specializes in reliable, accurate in vitro diagnostic testing solutions with a focus on clinical chemistry analysis. The company serves multiple market segments including human healthcare, veterinary diagnostics, and biopharmaceutical research and manufacturing. Based in West Caldwell, New Jersey, Alfa Wassermann maintains a long-established presence in the diagnostics and separation technology sectors.

Access Bio, Inc. is a global in vitro diagnostics (IVD) manufacturer headquartered in Monroe Township, New Jersey. The company specializes in rapid diagnostic tests and molecular diagnostics for infectious disease detection, with a primary focus on malaria, HIV, HPV, and COVID-19. Access Bio's product portfolio includes rapid point-of-care tests, COVID-19 antigen and molecular (PCR) assays, serology tests, and automated laboratory analyzers. The company has received multiple FDA Emergency Use Authorizations (EUA) for COVID-19 detection kits, including a 10-minute antigen test and molecular tests with results in 83 minutes or less. Access Bio serves international public health agencies, healthcare systems, and research organizations globally. The company holds FDA regulatory approvals and maintains manufacturing and distribution capabilities through established supply chain partnerships. Recent regulatory milestones include FDA-granted shelf-life extensions for the CareStart COVID-19 Antigen Home Test (extended to 21 months at 1–30°C storage). Access Bio is positioned as a leader in infectious disease diagnostics with operations across the US, South Korea, and other international markets. The company actively pursues partnerships with healthcare providers, educational institutions, and global health organizations to expand access to diagnostic solutions.

QuidelOrtho Corporation is a global in vitro diagnostics company providing diagnostic solutions across clinical laboratory, transfusion medicine, molecular testing, and point-of-care applications. The company offers over 550 assays across multiple testing modalities including real-time PCR, rapid lateral-flow immunoassays, automated immunohematology systems, and benchtop analyzers. Key product platforms include LYRA™ real-time PCR assays (open platform molecular testing), QUICKVUE™ rapid lateral-flow tests for infectious diseases and point-of-care diagnostics, TRIAGE™ System for point-of-care immunoassays, VITROS™ benchtop clinical chemistry systems, SOFIA™ 2 Analyzer for rapid diagnostics, ORTHO VISION™ Swift automated blood bank analyzers, ORTHO™ Workstation semi-automated immunohematology analyzer, and ORTHO OPTIX™ Reader for transfusion lab testing. The company serves clinical laboratories, hospitals, point-of-care settings, and home-testing markets in 140+ countries. QuidelOrtho recently completed acquisition of Lex Diagnostics, expanding its diagnostic portfolio. The company manufactures diagnostic instruments, reagents, and assays for infectious disease detection (virology, molecular, immunoassay), blood banking, clinical chemistry, and specialty testing. Products are regulated as in vitro diagnostic devices under FDA and international standards.

Cenogenics Corporation is an FDA-registered, ISO 13485:2016-certified manufacturer and marketer of high-quality diagnostic kits and reagents for clinical and professional applications. The company specializes in in vitro diagnostic (IVD) products including stool occult blood tests, febrile (Widal) antigens, colorectal cancer screening assays, Lyme disease serology, syphilis detection kits, and veterinary diagnostic test kits. The company offers complete private-label branding and contract manufacturing services, enabling partners to formulate and package diagnostic products tailored to their specifications. Cenogenics' manufacturing heritage includes Laboratory Diagnostics Company, among the earliest developers of guaiac occult blood slides, with their occult blood tests now used globally for early detection of colorectal cancer indicators. The company emphasizes consistent quality, ease of readability, competitive pricing, and optimized reactivity and sensitivity in all products. Services include private labeling, contract manufacturing, joint ventures, and distributor partnerships. Products are manufactured to international standards and supplied worldwide to clinical laboratories, healthcare providers, and diagnostic distributors.

Dealmed Medical Supplies LLC is a B2B medical supply distributor serving physicians, healthcare facilities, surgical centers, urgent care, dialysis facilities, health systems, emergency medical services, and retail channels across the United States. The company operates as an authorized distributor for nearly 300 brands, offering a comprehensive product portfolio spanning medical and surgical consumables, medical and office equipment, physician laboratory supplies and diagnostics kits, office management supplies, and pharmaceuticals. Product lines include examination gloves (nitrile), surgical gauze sponges, adhesive bandages, surgical tape, suture and staple removal kits, examination tables, patient monitoring systems (Welch Allyn Connex Spot Monitor), spirometers (NDD EasyOne Air), clinical laboratory analyzers (Diatron Abacus, Quidel Sofia), rapid diagnostic tests (Strep A, COVID-19 antigen, influenza), steam sterilizers (Midmark M11), drape sheets, table paper, emesis basins, underpads, and injectable pharmaceuticals including naloxone, calcium chloride, diphenhydramine, aspirin, and cyanocobalamin. Dealmed operates multiple distribution centers leveraging proprietary logistics technology to enable fast fulfillment through its own fleet and major carriers. The company provides Dealmed Runtime™, a proprietary online ordering and management platform offering automatic reporting, inventory alerts, and supply chain visibility. Services include GPO contract integration, 3PL capabilities, custom shipping solutions, and consultative procurement support. Dealmed markets itself on operational agility, guaranteed product authenticity and warranty coverage, and omnichannel distribution reach. Founded in 2008, the company serves diverse care models from individual practices to large integrated delivery networks and government/public sector entities.

Diagnostica Stago, Inc. (DSI) is a global leader in hemostasis and thrombosis diagnostics and testing. The company develops, manufactures, and distributes coagulation analyzers, reagents, quality control materials, and related services for clinical laboratory and hospital settings. Stago's product portfolio includes the STA product line of automated coagulation analyzers (including STA Max Generation 3), complementary reagents for hemostasis testing, and consumables for thrombosis and hemostasis assessment. The company provides comprehensive support through quality control programs (My Daily QC, My Expert QC, My Qualiris EQA), technical services, continuing education (Stago EdVantage), and webinar programs covering new tests and markers in hemostasis. Stago maintains ISO and regulatory compliance for its analyzers and reagents, with recent FDA clearance of the STA Max Generation 3. The company serves hospitals, clinical laboratories, and diagnostic centers across the United States and operates as part of the international Stago Group with subsidiaries in multiple countries. Customer support includes digital portals (My Personal Space), peer comparison networks (Clarity Peer Group), and access to safety documentation and instructions for use.

EUROIMMUN US, a subsidiary of the global leader EUROIMMUN Medizinische Labordiagnostika AG, is a manufacturer of in vitro diagnostic reagents and automation systems for clinical laboratory testing. The company specializes in immunodiagnostic assays and automated laboratory analyzers serving clinical laboratories, reference laboratories, and hospital laboratories across North America. Core product portfolios include autoimmune disease diagnostics, infectious disease serology (including viral serology for Zika, COVID-19, Oropouche, and other pathogens), allergy testing, endocrinology assays, bone metabolism markers, neurodegeneration biomarkers, and therapeutic drug monitoring. The company manufactures the IDS i20 random access chemiluminescent analyzer, AP2400 automated T-SPOT.TB testing system (FDA-approved), and distributes the ProciseDx platform. EUROIMMUN US offers training and education through its Academy and Pattern IQ learning platform for ANA pattern recognition. The company provides field service and technical support to laboratory customers. Products are designed for CLIA-certified clinical laboratories and diagnostic reference centers. The company is now part of the Revvity organization.